Biomarkers - Resources

21/10/24 - The radiotracer is the first part of Nuclidium’s proposed ‘theranostic pipeline’ which aims to diagnose, stage, and then treat prostate cancer.

Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.

A New Golden Age for Target Identification: Accessing the Novel Druggable Space with Discovery Proteomics

On-demand webinar presented by Mo Jain, MD, PhD, Founder and CEO, Sapient and Jonathan Usuka, PhD, MBA Chief Business Officer, Sapient

Watch Now

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.

Read Now

Content Type

Digital Biomarkers for Disease Detection and Monitoring

Beverley Patterson, Clinical Science Director at Ono Pharma UK Ltd, leads a Discussion Group on harnessing biomarker technologies to improve disease detection and tracking.

Diagnostic Development

Genetic Variants Linked to Dyslexia

A new study from the University of Edinburgh has identified potential gene indications associated with dyslexia.

Oxford Global's R&D Key 40 Stories 2022

Download a copy of the R&D Key 40 Stories 2022 eBook today

Diagnostic Development

Thirdhand Smoke Triggers Skin Disease

New research suggests acute exposure to thirdhand smoke elevates biomarkers associated with skin diseases.

Digital Biomarkers

Digital Biomarkers: Using Smartphones for the Passive Monitoring of Neurodegenerative Diseases

Smartphones, laptops and other household electronic devices could be optimised for the early detection of neurodegenerative diseases such as Alzheimer’s. Preventative monitoring approaches such as these could provide another avenue of detection to abet the provision of treatment.